Increase in serum concentration of FAS ligand as a possible mechanism for antithyroid cytotoxicity during autoimmune thyroid diseases.
We studied the dependence of serum cytotoxic activity on the contents of soluble apoptosis receptor and its soluble ligand in patients with autoimmune thyroid diseases.
Kandror
V I
VI
Research Center for Endocrinology, Russian Academy of Medical Sciences, Moscow. vik@mail
Babkina
I V
IV
Krainova
S I
SI
Kavtaradze
S R
SR
Kushlinskii
N E
NE
D017209:Apoptosis; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology; D016022:Case-Control Studies; D002478:Cells, Cultured; D004797:Enzyme-Linked Immunosorbent Assay; D053222:Fas Ligand Protein; D005260:Female; D006044:Goiter, Nodular / Q000276:immunology / Q000473:pathology; D006801:Humans; D008024:Ligands; D008297:Male; D008562:Membrane Glycoproteins / Q000097:blood*; D012426:Russia; D013602:T-Lymphocytes, Cytotoxic / Q000502:physiology*; D013967:Thyroiditis, Autoimmune / Q000276:immunology* / Q000473:pathology; D019014:fas Receptor / Q000502:physiology*
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008024:Ligands; D008562:Membrane Glycoproteins; D019014:fas Receptor